A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Stryker Corporation (Stryker or the Company) is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. Our core values guide our behaviors and actions and are fundamental to how we execute our mission. Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent orthopaedic surgeon and inventor of several medical products.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 25.1B | 25.1B | 22.6B | 20.5B | 18.4B | 17.1B |
| Net Income | 3.2B | 3.2B | 3.0B | 3.2B | 2.4B | 2.0B |
| EPS | $8.40 | $8.40 | $7.76 | $8.25 | $6.17 | $5.21 |
| Free Cash Flow | 4.3B | 4.3B | 3.5B | 3.1B | 2.0B | 2.7B |
| ROIC | 10.0% | 10.6% | 10.1% | 10.9% | 8.6% | 9.3% |
| Gross Margin | 64.0% | 64.0% | 63.9% | 63.7% | 62.8% | 64.1% |
| Debt/Equity | 0.75 | 0.75 | 0.73 | 0.81 | 0.86 | 0.84 |
| Dividends/Share | $3.32 | $3.32 | $3.16 | $2.97 | $2.75 | $2.48 |
| Operating Income | 4.9B | 4.9B | 3.7B | 3.9B | 2.8B | 2.6B |
| Operating Margin | 19.5% | 19.5% | 16.3% | 19.0% | 15.4% | 15.1% |
| ROE | 14.5% | 15.1% | 14.5% | 17.0% | 14.2% | 13.4% |
| Shares Outstanding | 386M | 386M | 386M | 384M | 382M | 383M |
STRYKER CORP passes 5 of 9 quality checks, suggesting mixed fundamentals.
STRYKER CORP trades at 41.3x trailing earnings, compared to its 15-year median P/E of 40.0x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 31.0x vs a median of 36.1x. The company's 5-year average ROIC is 9.9% with a gross margin of 63.7%. Total shareholder yield (dividends) is 1.0%. At current prices, the estimated annualized return to fair value is +10.5%.
STRYKER CORP (SYK) has a current P/E ratio of 41.3, compared to its historical median P/E of 40.0. The stock is currently considered Fair based on its historical valuation range.
STRYKER CORP (SYK) has a 5-year average return on invested capital (ROIC) of 9.9%. This is below average and may indicate limited pricing power.
STRYKER CORP (SYK) has a market capitalization of $134.2B. It is classified as a large-cap stock.
Yes, STRYKER CORP (SYK) pays a dividend with a trailing twelve-month yield of 0.96%.
Based on historical P/E analysis, STRYKER CORP (SYK) appears fair. The current P/E of 41.3 is 3% above its historical median of 40.0. The estimated fair value CAGR (P/E method) is 5.8%.
STRYKER CORP (SYK) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
STRYKER CORP (SYK) reported annual revenue of $25.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
STRYKER CORP (SYK) has a net profit margin of 12.9%. This is a healthy margin.
STRYKER CORP (SYK) generated $4.3 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
STRYKER CORP (SYK) has a debt-to-equity ratio of 0.75. This indicates moderate leverage.
STRYKER CORP (SYK) reported earnings per share (EPS) of $8.40 in its most recent fiscal year.
STRYKER CORP (SYK) has a return on equity (ROE) of 15.1%. This indicates the company generates strong returns for shareholders.
STRYKER CORP (SYK) has a 5-year average gross margin of 63.7%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 19 years of financial data for STRYKER CORP (SYK), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
STRYKER CORP (SYK) has a book value per share of $58.02, based on its most recent annual SEC filing.
No recent press releases.